A New Destination for Oncology Education
September 15, 2025 | PIONEER, medical education, precision oncology
Medscape Oncology is pleased to announce the launch of a groundbreaking new learning space designed to provide education across tumor types and oncology disciplines: PIONEER – PrecIsion Oncology: Navigating EvidEnce for Real-world impact. This dedicated platform offers comprehensive, structured CME, organizing content by therapeutic target and tumor type to reflect the latest clinical and therapeutic advances. The result is a sharper focus on the science driving treatment decisions, ensuring physicians have the tools to deliver truly personalized care.
“This new learning center is all about providing clinicians with a one-stop destination for structured, consolidated CME, and helping them stay at the forefront of precision oncology to connect more patients with life-changing care. This is a vital resource for clinicians across oncology, and one we’re very proud to provide.” said Zhizhi Fiske, PhD, Director of Clinical Strategy at Medscape Education.
Surveys of Medscape physicians have found that 97% of physicians use biomarker or molecular target information when making treatment decisions. However, 85% of physicians frequently or occasionally encounter challenges in identifying appropriate therapies for patients with actionable mutations. Furthermore, 90% of physicians agree that a cross-tumor, target-based educational program would enhance their clinical decision-making.
“We surveyed over 100 physicians in the U.S. and E.U. The message was clear: doctors are eager to use biomarkers to guide treatment but struggle to keep up with rapid developments. Our findings confirm that while most find existing CME helpful, there is strong demand for interactive biomarker modules, expert panel discussions, and cross-tumor, target-based programs. A recurring theme was the desire for all these resources in one easily accessible place.” said Nabil Dorkhom, MD, Director Clinical Strategy at Medscape Education.
PIONEER is led by a distinguished steering committee of physician experts, including committee chair Fabrice André, MD, PhD, Head of Research, Professor of Oncology, Gustave Roussy, Villejuif, France; Benedikt Westphalen, MD, PhD, Chair, Center for Personalised Medicine,University Hospital, University of Munich, Munich, Germany; Vivek Subbiah, MD, Chief, Early-Phase Drug Development Sarah Cannon Research Institute,Nashville, Tennessee, United States; and Mary Beth Beasley, MD, Professor of Pathology, Head, Thoracic Pathology, Icahn School of Medicine at Mt. Sinai Medical Center, New York, United States.
“Precision oncology is revolutionizing cancer treatment, shifting from broad-spectrum therapies to precisely targeted interventions based on each patient’s unique molecular profile. For healthcare professionals, effective education and readily accessible, centralized information are paramount. This empowers them to harness cutting-edge diagnostics and apply optimized, individualized therapeutic strategies, ultimately improving patient outcomes,” commented committee chair Dr Fabrice André.
Physicians can start learning on the PIONEER microsite here.
Follow us on LinkedIn to stay up to date with the latest news and perspectives
About Medscape Education
Medscape Education is the leading online platform for continuing medical education (CME) and continuing education (CE), trusted by millions of healthcare professionals worldwide. With more than 30 speciality-specific learning destinations, it offers thousands of free, accredited courses for physicians, nurses, pharmacists, and other healthcare professionals. Medscape Education delivers high-impact, evidence-based education designed to support clinical decision-making, improve patient outcomes, and keep healthcare professionals current in a rapidly evolving medical landscape.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Advancing Patient-Centered Cancer Care Through Education to #CloseTheCareGap
One of the next frontiers in oncology isn’t being explored in a lab. Instead, it’s advancing in hospitals and private clinics around the world, thanks to the hard work of...
Medscape Education’s Dedication to Delivering Impact to be Highlighted at Alliance Annual Meeting 2024
Being an active part of the continuing medical education community is a top priority for the Medscape Education team. As part of their commitment to sharing their insights and learnings...
We Can Shorten the Journey
During the shortest month of the year, Medscape Education is making a renewed commitment to use clinician education to help shorten the diagnostic and treatment journey for the millions of...
Making an Impact at ASH 2023
Medscape has left behind the sunny skies of San Deigo, having attended their final conference of the year at the ASH annual meeting.The team wrapped up the year with a...
Women’s Health Faces Some Difficult Headwinds. Here’s How We Can Move Forward
When it comes to women’s health, “we are a bit behind — almost where oncology was 20 years ago and neuroscience was about 10 years ago,” says Sandra Milligan, Head...
A “Leaky Pipeline” and the Loss of Talented Female Physicians
A leaky pipeline that begins during medical school and extends throughout the training process means we lose many talented women, says Fatima Rodriguez, director of preventive cardiology and associate professor...
Medscape Oncology’s Large Presence at ASH 2023
Medscape Education is returning to the annual ASH conference with eight symposia, two publications, and the opportunity for clinicians to challenge their knowledge with MedChallenge.The eight symposia will be held...